Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001789769-24-000008
Filing Date
2024-01-10
Accepted
2024-01-10 19:49:39
Documents
1
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704934169.html 4  
1 FORM 4 wk-form4_1704934169.xml 4 3874
  Complete submission text file 0001789769-24-000008.txt   5337
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Gibson Neil W (Reporting) CIK: 0001555918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40215 | Film No.: 24527711

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)